• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

精神分裂症患者黑质中的多巴胺D2受体

Dopamine D2 receptors in substantia nigra in schizophrenia.

作者信息

Owen R, Owen F, Poulter M, Crow T J

出版信息

Brain Res. 1984 May 7;299(1):152-4. doi: 10.1016/0006-8993(84)90798-4.

DOI:10.1016/0006-8993(84)90798-4
PMID:6144367
Abstract

Dopamine D2 receptors were assessed in samples of substantia nigra from controls and schizophrenics. Specific [3H]spiperone binding was significantly increased in both neuroleptic-free and neuroleptic-treated schizophrenics. This supports our previous suggestion that the increase in D2 receptors observed in striatum of schizophrenics is not wholly due to neuroleptic medication.

摘要

在对照组和精神分裂症患者的黑质样本中评估了多巴胺D2受体。在未服用抗精神病药物和服用抗精神病药物治疗的精神分裂症患者中，特异性[3H]螺哌隆结合均显著增加。这支持了我们之前的观点，即精神分裂症患者纹状体中观察到的D2受体增加并非完全归因于抗精神病药物治疗。

相似文献

1
Dopamine D2 receptors in substantia nigra in schizophrenia.精神分裂症患者黑质中的多巴胺D2受体
Brain Res. 1984 May 7;299(1):152-4. doi: 10.1016/0006-8993(84)90798-4.
2
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.精神分裂症患者尸检大脑中的3H-螺哌隆结合位点：与抗精神病药物治疗、异常运动及阳性症状的关系
J Neural Transm. 1989;75(1):1-10. doi: 10.1007/BF01250639.
3
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.正电子发射断层扫描显示，未使用过药物的精神分裂症患者体内D2多巴胺受体水平升高。
Science. 1986 Dec 19;234(4783):1558-63. doi: 10.1126/science.2878495.
4
D1 and D2 dopamine receptors in human substantia nigra: localization and the effect of aging.人类黑质中的D1和D2多巴胺受体：定位及衰老的影响。
J Neurochem. 1991 Apr;56(4):1130-3. doi: 10.1111/j.1471-4159.1991.tb11402.x.
5
Elevation of brain neuroleptic/dopamine receptors in schizophrenia.精神分裂症患者大脑中神经安定剂/多巴胺受体水平升高。
Am J Psychiatry. 1980 Feb;137(2):191-7. doi: 10.1176/ajp.137.2.191.
6
Abnormal neuroleptic/dopamine receptors in schizophrenia.精神分裂症中异常的抗精神病药物/多巴胺受体。
Adv Biochem Psychopharmacol. 1980;21:435-42.
7
Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.精神分裂症患者大脑中尾状核和壳核多巴胺受体的改变。
Med Biol. 1986;64(6):351-4.
8
Increase in D2 dopamine receptors in the substantia nigra after chronic (-)-sulpiride treatment.长期使用（-）-舒必利治疗后黑质中D2多巴胺受体增加。
Brain Res. 1991 Aug 2;555(2):340-2. doi: 10.1016/0006-8993(91)90362-y.
9
Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.大鼠黑质中突触前多巴胺敏感性腺苷酸环化酶与[3H]螺哌隆结合位点之间的解离。
Brain Res. 1979 May 11;167(2):355-65. doi: 10.1016/0006-8993(79)90829-1.
10
Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.路易体痴呆中黑质纹状体多巴胺能活动与抗精神病药物敏感性的关系：与帕金森病的比较
Biol Psychiatry. 1998 Oct 15;44(8):765-74. doi: 10.1016/s0006-3223(98)00127-9.

引用本文的文献

1
The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics.苯丁胺在服用抗精神病药物的精神病患者中用于治疗肥胖症的应用
Psychiatry Investig. 2023 Sep;20(9):799-807. doi: 10.30773/pi.2023.0045. Epub 2023 Sep 19.
2
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.高催乳素血症和催乳素瘤管理中的争议问题——巴西内分泌与代谢学会神经内分泌学部门概述
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):236-263. doi: 10.20945/2359-3997000000032.
3
Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.
黑质应激诱导的临床高风险和抗精神病药物初治精神分裂症中的多巴胺释放。
Schizophr Bull. 2018 Apr 6;44(3):542-551. doi: 10.1093/schbul/sbx042.
4
Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.来自人类中脑尸检的分子证据支持了精神分裂症中假定的突触前多巴胺调节异常。
Transl Psychiatry. 2017 Jan 17;7(1):e1003. doi: 10.1038/tp.2016.257.
5
Comparison between the efficacies of Risperidone with Haloperidol in the treatment of attention-deficit hyperactivity disorder (ADHD) among preschoolers: a randomized double-blind clinical trial.利培酮与氟哌啶醇治疗学龄前儿童注意力缺陷多动障碍（ADHD）的疗效比较：一项随机双盲临床试验。
Electron Physician. 2016 Sep 20;8(9):2840-2848. doi: 10.19082/2840. eCollection 2016 Sep.
6
Neuropathological changes in the substantia nigra in schizophrenia but not depression.精神分裂症患者黑质存在神经病理学改变，而抑郁症患者则无。
Eur Arch Psychiatry Clin Neurosci. 2014 Jun;264(4):285-96. doi: 10.1007/s00406-013-0479-z. Epub 2013 Dec 29.
7
The dopamine dilemma: using stimulants and antipsychotics concurrently.多巴胺困境：同时使用兴奋剂和抗精神病药物。
Psychiatry (Edgmont). 2010 Jun;7(6):18-23.
8
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.精神分裂症的基底神经节病理学：多巴胺连接和异常。
J Neurochem. 2010 Apr;113(2):287-302. doi: 10.1111/j.1471-4159.2010.06604.x. Epub 2010 Jan 20.
9
Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.精神分裂症患者纹状体、丘脑、黑质、边缘系统区域及皮质中的多巴胺D2受体水平。
Biol Psychiatry. 2009 Jun 15;65(12):1024-31. doi: 10.1016/j.biopsych.2008.12.029. Epub 2009 Feb 28.
10
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.精神分裂症患者尸检大脑中的3H-螺哌隆结合位点：与抗精神病药物治疗、异常运动及阳性症状的关系
J Neural Transm. 1989;75(1):1-10. doi: 10.1007/BF01250639.